Correlation Between Syndax Pharmaceuticals and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Crinetics Pharmaceuticals.
Diversification Opportunities for Syndax Pharmaceuticals and Crinetics Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Syndax and Crinetics is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.63 times more return on investment than Crinetics Pharmaceuticals. However, Syndax Pharmaceuticals is 1.58 times less risky than Crinetics Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.36 per unit of risk. If you would invest 1,285 in Syndax Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 23.00 from holding Syndax Pharmaceuticals or generate 1.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Crinetics Pharmaceuticals |
Syndax Pharmaceuticals and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Crinetics Pharmaceuticals
The main advantage of trading using opposite Syndax Pharmaceuticals and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |